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SUMMARY
The incidence of Candida bloodstream infection has increased over the past years. In the Center-West region of Brazil, data on 
candidemia are scarce. This paper reports a retrospective analysis of 96 cases of Candida bloodstream infection at a Brazilian tertiary-
care teaching hospital in the state of Mato Grosso do Sul, from January 1998 to December 2006. Demographic, clinical and laboratory 
data were collected from medical records and from the hospital’s laboratory database. Patients’ ages ranged from three days to 92 
years, with 53 (55.2%) adults and 43 (44.8%) children. Of the latter, 25 (58.1%) were newborns. The risk conditions most often found 
were: long period of hospitalization, utilization of venous central catheter, and previous use of antibiotics. Fifty-eight (60.4%) patients 
died during the hospitalization period and eight (13.7%) of them died 30 days after the diagnosis of candidemia. Candida albicans 
(45.8%) was the most prevalent species, followed by C. parapsilosis (34.4%), C. tropicalis (14.6%) and C. glabrata (5.2%). This is 
the first report of Candida bloodstream infection in the state of Mato Grosso do Sul and it highlights the importance of considering 
the possibility of invasive Candida infection in patients exposed to risk factors, particularly among neonates and the elderly.
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INTRODUCTION
Systemic fungal infections are pathologies that particularly affect 
immunocompromised and severely ill patients1. Epidemiological studies 
have shown an increasing incidence of bloodstream infection by yeasts 
of the genus Candida, given their colonization ability and opportunism 
and the therapeutic challenges arising from the development of resistance 
to some antifungal agents2,6.
Candida infections are mostly endogenous and may result from 
proliferation or changes of the normal human microbiota, determined 
by risk factors such as long-term administration of broader-spectrum 
antibiotics, surgery, organ transplant, prematurity, use of invasive 
procedures (e.g. those involving catheters for nasogastric, urinary, 
parenteral nutrition, hemodialysis, or mechanic ventilation purposes), 
and other treatment actions3,7,11.
The pathogenic potential of the genus varies considerably, and C. 
albicans is the species most frequently found in clinical samples1,4. C. 
parapsilosis and C. tropicalis, however, are also regarded as important 
candidemia agents10,12. 
An additional aggravating factor is the high morbidity and mortality 
rate associated with systemic candidemia, ranging from 40% to 60%, 
according to different studies1,2,9,11.
Given the relevance of the issue and considering that the epidemiology 
of systemic Candida infections varies across regions and even across 
hospitals within a single region3,5,11, the present study is focused on a 
series of candidemia cases that occurred at a teaching hospital located 
in the Center-West region of Brazil.
MATERIAL AND METHODS
A retrospective study was conducted to describe the prevalence of 
Candida species in blood cultures and the risk factors associated with 
candidemia at the tertiary-care teaching hospital of Universidade Federal 
de Mato Grosso do Sul (UFMS), in Campo Grande, Brazil.
The patients had been admitted to various hospital divisions - namely, 
adult intensive care center, medical clinic, surgical clinic, hematology 
sector, oncology division, parasitic infectious diseases, renal unit, 
neonatal intensive care unit, pediatric intensive care center, pediatric 
clinic, and nursery.
In order to be included in the study, a patient should have tested 
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positive to Candida spp. in at least one culture of blood drawn from a 
peripheral vein, in addition to exhibiting clinical evidence of sepsis.
The yeasts isolated from blood cultures were detected using a 
Bactec 9120 system (Becton Dickinson, INC, Sparks, MD). Positive 
samples were Gram-stained, grown on Sabouraud agar and brain-heart 
infusion agar, and incubated at 37 ºC at room temperature until growth 
was observed. After screening with the germ tube test, the isolates were 
identified according to microscopic morphology on cornmeal - Tween 80 
agar, auxanogram test, growth at 42 ºC, and confirmation by means of an 
automated Vitek system (BioMérieux, St. Louis, MO, USA)8. 
Medical records were reviewed and clinical data were analyzed in 
conjunction with the respective laboratory data using the software Epi 
Info 3.3.0.2 (Centers for Disease Control and Prevention, Atlanta, GA, 
USA). The study was approved by the Ethics Committee for Clinical 
Research of UFMS.
RESULTS
The cases of Candida bloodstream infection included in the study 
occurred in the period from January 1998 to December 2006, comprising 
96 patients, 53 (55.2%) of them adults and 43 (44.8%) children. Of 
the pediatric patients, 20 were newborns (46.5%), 24 (55.8%) were 
premature, and 19 (44.2%) had very low birth weight. Fifty patients 
(52.1%) were male and 46 (48.2%) female. Ages ranged from three days 
to 92 years, with a mean of 30 years. Candidemia episodes were more 
frequent among newborns (20.8%) and elderly patients (21.9%).
Hospital stays lasted from four to 124 days, with a mean duration of 
34 days. Most patients (63.5%) were admitted to the intensive care unit. 
Clinical and demographic data are reported in Table 1.
The most frequent comorbidities were pneumonia (43.8%) and 
gastrointestinal tract disease (33.4%). The underlying conditions more 
often observed were: hematological disease (leukemia, lymphoma), in 
12 cases (12.5%); diabetes mellitus, in 10 (10.4%); and solid tumors, 
in nine (9.4%). The overall mortality rate was 56.3%, reaching as much 
as 80.9% (17/21) among adults older than 60 years and 70.0% (14/20) 
among newborns.
Table 2 shows the main conditions posing a risk of candidemia. For 
all age groups, invasive procedures and hospitalization for 15 days or 
longer were the occurrences most often associated with candidemia. 
Additional risk factors among pediatric patients included: hospital stay 
longer than 15 days (76.7%), prematurity (55.8%), and very low birth 
weight (44.2%). Overall, previous use of antibiotics occurred in 93 
patients (97%), with 73% using four or more antibiotics. Most surgical 
(71.4%) and assisted-ventilation procedures (61.9%) were performed on 
patients older than 60 years.
C. albicans (44 cases; 45.8%) was the species most often isolated 
from blood cultures, followed by C. parapsilosis (33 cases; 34.4%), C. 
tropicalis (14; 14.6%), and C. glabrata (five; 5.2%). Table 3 shows the 
distribution of Candida species by three-year periods. 
Mortality rates varied according to Candida species, being higher for 
C. tropicalis (12/14; 85.7%) and C. glabrata (4/5; 80.0%).
Fifty-nine patients (61.4%) received antifungal treatment. 
Fluconazole was administered to 34 patients and amphotericin B to six. 
Nineteen patients were treated with both antifungal drugs. 
DISCUSSION
This is the first description of Candida bloodstream infection at a 
Brazilian tertiary-care teaching hospital in the Brazilian State of Mato 
Grosso do Sul. It provides information on species distribution and on the 
clinical features and outcomes among patients with candidemia. 
The literature reports a progressive increase in candidemia frequency 
in hospitalized patients1,5. These infections are generally difficult to 
diagnose, are refractory to treatment, and have an attributable mortality 
rate of 40-60%1,2,5,6.
In agreement with other studies6,9,10,11, most episodes of candidemia 
seen in this series of cases occurred in adults and children in intensive 
care units - the very wards were critical patients remain bedridden and 
are subject to alterations in defense mechanisms or to compromised 
anatomical barrier, secondary to invasive medical procedures.
Patients in extreme age ranges were the most susceptible, with 
fatal outcomes in all those older than 80 years. Overall, the underlying 
conditions and comorbidities identified in this study were similar to those 
reported in other investigations2,4.
Table 1
Patients with candidemia according to age group underline conditions and 
outcome 
Characteristics Patients (n = 96) %
Age group *
0 - 30 days 20 20.8
31 days - 2 years old 18 18.8
>2 - 12 years old 5 5.2
>12 - 25 years old 7 7.3
>25 - 40 years old 9 9.4
>40 - 60 years old 16 16.7
>60 years old 21 21.9
Location
Nursery 35 36.5
ICU 61 63.5
Underlying diseases
Pulmonar disease 42 43.8
Gastrointestinal tract disease 33 33.4
Hematology disease 12 12.5
Diabetes mellitus 10 10.4
Neoplasia (solid tumors ) 9 9.4
Evolution
Death 58 60.4
Discharge 42 39.6
* Age at time first positive blood culture.
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The present results add evidence to the already recognized risk of 
invasive candidemia, especially in neonatal and elderly inpatients. Use of 
central venous catheter and previous administration of antibiotics were 
the principal conditions posing a risk of candidemia, irrespective of age. 
Prolonged hospital stays may also have collaborated with the occurrence 
of bloodstream infection. These conditions are already recognized as 
important factors of risk for opportunistic infections, among them those 
caused by Candida spp.2,3,4,11.
The capacity of yeasts to attach to a wide range of inanimate 
surfaces (such as those of intravascular devices) and to form biofilms 
in glucosilated solutions seems to protect them from immune responses 
and antimicrobial agents7. This may explain why Candida species were 
associated with the use of central venous catheters and parenteral nutrition 
in the present study10. Gastrointestinal disorders were observed in 30-
40% of the patients, an occurrence that may have favored yeast invasion 
into the bloodstream5. 
In the present investigation, C. albicans was the species most often 
isolated from both adult and pediatric patients, although its yearly 
frequency did not significantly differ from those of other Candida 
species (p = 0.303). 
In the past three years, however, cases of C. parapsilosis outnumbered 
those from previous years, while cases of C. tropicalis decreased in 
number (Table 3). That increase may be associated with interventional 
therapy, including the growing use of central venous catheters, parenteral 
nutrition, and large-spectrum antibiotics for long periods10. Although 
the literature reports C. parapsilosis as being more frequent in pediatric 
patients1,6,10,11,12, the present study did not reveal any significant difference 
between adults (34.0%) and children (34.9%).
C. tropicalis was more often isolated from adult patients, a finding 
consistent with other studies4,12 reporting that this species is not common 
in pediatric patients, and even less so among neonates. C. glabrata was 
more frequent in adults (4/5).
Mortality rates for each Candida species were similar to those 
revealed by studies carried out in southern Brazil, where C. glabrata and 
C. tropicalis were associated with the highest death rates2.
The high mortality rate (56.3%) in the present series, similar to that 
found in other studies1,2,4,5,10, is a strong reason for health teams to be 
aware of risk factors potentially leading to Candida spp. infection - a 
reminder that prevention and control methods should be pre-emptively 
implemented. 
In the present case series, only 59 patients (61.4%) received antifungal 
treatment. The absence of treatment may be attributed to a lack of clinical 
recognition that candidemia can occur in severely ill patients or to delays 
in obtaining blood culture results.
Table 2
Risk factor for the development of candidemia acording to age group. Teaching Hospital of the Federal University of Mato Grosso do Sul (UFMS), 
Brazil, 1998 to 2006
Risk factor Pediatrics 
3 days ≤ 12 years 
n = 43
Adults 
> 12 to < 60 years old 
n = 32 
Adults 
> 60 years old 
n = 21
Hospitalization > 15 days 33 (76.7) 19 (52.4) 14 (66.7)
Very-low-birth-weight* 19 (44.2) - -
Prematurity** 24 (55.8) - -
Central venous catheter use 40 (93.0) 27 (84.4) 15 (71.4)
Other foreign bodies /catheters 33 (76.7) 22 (68.8) 16 (76.2)
Assisted ventilation 26 (60.4) 13 (40.6) 13 (61.9)
Antibiotics use 
Third-generation cephalosporin  30 (69.7) 15 (46.8) 10 (47.6)
Vancomycin 34 (79.1) 19 (61.3) 10 (47.6)
Carbapenems 22 (51.2) 12 (38.7) 11 (52.4)
Surgical procedure 19 (44.1) 20 (62.5) 15 (71.4)
* Birth-weight < 2500 g ,** Old gestational age ≤ 37 weeks.
Table 3 
Cause of fungemia: distribution of Candida species over time. Teaching 
Hospital at the Federal University of Mato Grosso do Sul (UFMS), Brazil, 
1998-2006
Species 1998-2000 2001-2003 2004-2006
Candida albicans (n = 44) 11 (35.5) 16 (53.3) 17 (48.6)
Candida parapsilosis (n = 33) 12 (38.7) 7 (23.3) 14 (40.0)
Candida tropicalis (n = 14) 7 (22.6) 5 (16.7) 2 (5.7)
Candida glabrata (n = 5) 1 (3.2) 2 (6.7) 2 (5.7)
Total 31 (32.3) 30 (31.2) 35 (36.5)
Chi-squared test for trend. Non-albicans species were added together.
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These are relevant issues in the management of patients, as pre-
emptive therapy should be instituted earlier whenever infections of fungal 
etiology are suspected.
Cases of candidemia are possibly underestimated in the hospital 
investigated, since this retrospective study only included documented 
infections, and blood cultures may often lack adequate sensitivity1. 
Candidemia is thus of greater prevalence than the available data may 
suggest, since blood culture, albeit a gold standard test, can possibly 
identify only a small fraction of the total number of cases. PCR-based 
assays are expected to provide further assistance in the future, increasing 
the sensitivity of screening methods12.
The present findings corroborate the relevance of epidemiological 
studies in monitoring bloodstream infections. 
RESUMO
Infecção na corrente sangüínea por Candida spp. dados de um 
hospital universitário em Mato Grosso do Sul, Brasil
A incidência de infecções na corrente sangüínea causada por Candida 
spp. tem aumentado nos últimos anos. Na região Centro-Oeste do Brasil, os 
dados sobre candidemia são escassos. Realizamos uma análise retrospectiva 
de casos de infecção na corrente sangüínea por Candida em um hospital 
terciário de ensino de Mato Grosso do Sul. Noventa e seis episódios 
diagnosticados de janeiro de 1998 a dezembro de 2006 foram incluídos no 
estudo. Os dados demográficos e clínicos foram obtidos de prontuários; os 
dados laboratoriais provieram de registros do laboratório hospitalar. Dos 
pacientes, 43 (44,8%) eram crianças e 53 (55,2%) adultos, com idades 
variando de três dias a 92 anos. Das crianças, 25 (58,1%) eram recém-
nascidas. As condições de risco mais encontradas foram: prolongado tempo 
de internação, uso de cateter venoso central e uso prévio de antibióticos. 
Cinqüenta e oito (60,4%) pacientes foram a óbito durante a hospitalização e 
oito (13,7%) deles foram a óbito 30 dias após o diagnóstico de candidemia. 
Candida albicans (45,8%) foi a espécie mais prevalente seguida por C. 
parapsilosis (34,4%), C. tropicalis (14,6%) e C. glabrata (5,2%). Esta é a 
primeira descrição de infecção na corrente sangüínea por espécies de Candida 
em Mato Grosso do Sul, confirmando a importância da suspeita clínica 
de infecções invasivas por tais microrganismos na evolução de pacientes 
expostos a fatores de risco, principalmente no caso de idosos e neonatos.
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